| Trastuzumab for the treatment of salivary duct carcinoma SA Limaye, MR Posner, JF Krane, M Fonfria, JH Lorch, DA Dillon, ... The oncologist 18 (3), 294-300, 2013 | 188 | 2013 |
| ALK fusions in the pan-cancer setting: another tumor-agnostic target? A Shreenivas, F Janku, MA Gouda, HZ Chen, B George, S Kato, ... NPJ Precision Oncology 7 (1), 101, 2023 | 34 | 2023 |
| Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer J Zenga, V Divi, M Stadler, B Massey, B Campbell, M Shukla, M Awan, ... Oral Oncology 98, 125-131, 2019 | 31 | 2019 |
| Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant … Y Inamoto, I Petriček, L Burns, S Chhabra, Z DeFilipp, P Hematti, A Rovó, ... Bone marrow transplantation 54 (5), 648-661, 2019 | 22 | 2019 |
| A single-institution experience of performing bloodless transplant in Jehovah’s Witness patients A Coltoff, A Shreenivas, S Afshar, A Steinberg Hematology/oncology and stem cell therapy 12 (1), 44-49, 2019 | 18 | 2019 |
| Non-graft-versus-host disease ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the … Y Inamoto, I Petriček, L Burns, S Chhabra, Z DeFilipp, P Hematti, A Rovó, ... Biology of blood and marrow transplantation 25 (5), e145-e154, 2019 | 17 | 2019 |
| A rare case of insulinoma presenting with postprandial hypoglycemia AV Shreenivas, V Leung The American journal of case reports 15, 488, 2014 | 17 | 2014 |
| Emerging drugs for the treatment of myelofibrosis A Shreenivas, J Mascarenhas Expert Opinion on Emerging Drugs 23 (1), 37-49, 2018 | 15 | 2018 |
| Excellent response with alpelisib and bicalutamide for advanced salivary duct carcinoma with PIK3CA mutation and high androgen receptor expression—A case report H Sheth, P Kumar, A Shreenivas, J Sambath, R Pragya, C Madre, ... JCO Precision Oncology 5, PO. 20.00436, 2021 | 13 | 2021 |
| Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation L North, M Stadler, B Massey, B Campbell, M Shukla, M Awan, CJ Schultz, ... American Journal of Otolaryngology 40 (6), 102282, 2019 | 13 | 2019 |
| Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia SK Tahir, E Calvo, BA Carneiro, J Yuda, A Shreenivas, ... Blood 141 (17), 2114-2126, 2023 | 11 | 2023 |
| Chronic stress promotes an immunologic inflammatory state and head and neck cancer growth in a humanized murine model J Zenga, MJ Awan, A Frei, E Petrie, GP Sharma, A Shreenivas, M Shukla, ... Head & neck 44 (6), 1324-1334, 2022 | 9 | 2022 |
| Oral mucositis—case series of a rare adverse effect associated with immunotherapy H Sheth, R Pragya, S Kovale, M Deshpande, R Mistry, A Shreenivas, ... Supportive Care in Cancer 29, 4705-4709, 2021 | 8 | 2021 |
| Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy R Nagarkar, D Patil, S Limaye, P Devhare, A Ghaisas, N Srivastava, ... Oncotarget 11 (45), 4195, 2020 | 6 | 2020 |
| The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon … S Chakrabarti, M Parish, C Peterson, KA Ludwig, D Sriram, A Ruggeri, ... Journal of Clinical Oncology 41 (4_suppl), 105-105, 2023 | 5 | 2023 |
| Genomic profiling and precision medicine in complex ameloblastoma JSR James C Gates , Allison P Clark , Elliot Cherkas , Aditya V Shreenivas ... Head & Neck, https://pubmed.ncbi.nlm.nih.gov/36645099, 2023 | 5* | 2023 |
| A rare case of factor V inhibitor in a patient on amiodarone therapy AV Shreenivas, J Lipshitz, D Patel Blood coagulation & fibrinolysis 23 (4), 342-344, 2012 | 5 | 2012 |
| The efficacy and safety of immune checkpoint inhibitors in adrenocortical carcinoma: A systematic review and meta-analysis O Ababneh, A Ghazou, M Alawajneh, S Alhaj Mohammad, A Bani-Hani, ... Cancers 16 (5), 900, 2024 | 4 | 2024 |
| MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS-mutated advanced pancreatic ductal adenocarcinoma (PDAC). M Mehdi, SZ Thalji, AV Shreenivas, S Chakrabarti, JP Thomas, ... Journal of Clinical Oncology 40 (16_suppl), e16260-e16260, 2022 | 4 | 2022 |
| Who knows the nose?–The tale of esthesioneuroblastoma and sinonasal neuroendocrine carcinoma S Limaye, A Shreenivas Cancer Research, Statistics, and Treatment 3 (2), 293-295, 2020 | 4 | 2020 |